The Drug Price Negotiation Program already has changed how the company considers the development of future oncology programs and medications. 

Prior to March and April of 2023, operating margins sat in the red for 15 consecutive months.

“This research shows the clear financial benefits when hospitals and health systems offer telemedicine services directly to their own employees."

A new analysis reveals that insurers could put between $228 million and $2.15 billion back in taxpayers’ pockets by purchasing a series of generic oncology medications at the same prices obtained by the Mark Cuban Cost Plus Drug Company.

Merck believes the Inflation Reduction Act-launched effort “coerces” manufacturers to enter into agreements to sell their top products at a fraction of their actual value.

The audit revealed that Medicare overpaid by approximately $22.5 million due to incorrect place-of-service coding completed by practitioners.  

A total of 80 healthcare companies are among those that brought in the most revenue for the fiscal year, according to the magazine's most recent rankings.

The two companies first started collaborating on diabetes technology in 2021. The acquisition is not yet final, but Novo Nordisk now holds the exclusive negotiation rights.